Vizgen operates a spatial biology platform (MERSCOPE Ultra, MERFISH, InSituPlex) that combines single-cell genomics with spatial analysis and AI-driven image processing. The tech stack is split: frontend (React, TypeScript, Chakra UI), backend infrastructure (Node.js, Python, PostgreSQL, AWS), and lab/research tools (RNA-seq). Active projects cluster heavily around consumables forecasting, sales funnel optimization, and demand generation—suggesting the company is scaling go-to-market operations faster than core product development velocity.
Vizgen, formed through the merger of Vizgen and Ultivue, develops hardware and software for spatial multiomics analysis in research settings. The MERSCOPE platform enables researchers to map gene expression at single-cell resolution within intact tissue samples, supporting foundational and translational research in disease mechanisms and cell biology. The company operates from Cambridge, Massachusetts and sells consumables (assays, reagents) and instruments to academic and clinical research labs. Internal priorities reflect a maturing commercial organization: forecasting, sales process standardization, analytics infrastructure, and regional market expansion.
Frontend: React, TypeScript, Chakra UI. Backend: Node.js, Python, PostgreSQL, AWS Lambda. QA: Selenium, Playwright, Cypress, TestComplete. CI/CD: GitHub Actions, GitLab CI, Jenkins. Lab tools: RNA-seq analysis. CRM/Operations: Salesforce, NetSuite, HubSpot.
Vizgen is headquartered in Cambridge, Massachusetts. All active hiring is currently in the United States.
Other companies in the same industry, closest in size